Clinical Trials Directory

Trials / Completed

CompletedNCT02775682

Cerebral Autoregulation in Patients With Epilepsy

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Yi Yang · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether patients with epilepsy exhibiting impaired dCA, which may contribute to subsequent stroke.

Detailed description

The relationship between epileptic seizures and cerebrovascular disease is complex, ranging from mechanisms to clinical manifestation. Stroke is one of the most common causes of epilepsy in adulthood. It was also reported that patients with epilepsy exhibited a higher risk of stroke. But its potential mechanism was never fully understood. Dynamic cerebral autoregulation(dCA), a mechanism to maintain the cerebral bold flow, has been proved to be critical for the occurrence ,development and prognosis of ischemic neurovascular disease. In this study, we hypothesis that impaired dCA play a role in epilepsy and subsequent stroke.

Conditions

Timeline

Start date
2016-04-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2016-05-18
Last updated
2021-08-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02775682. Inclusion in this directory is not an endorsement.

Cerebral Autoregulation in Patients With Epilepsy (NCT02775682) · Clinical Trials Directory